
John Misasi
Assistant Professor, Boston University Chobanian & Avedisian School of Medicine · Boston University Medical Center
Credentials: · ·
History
Research
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection
Nature · 2011 · 577 citations
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Cell Reports · 2022 · 369 citations
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Science · 2016 · 349 citations
- JM
23 papers
- EP
8 papers
- JL
8 papers
- MG
8 papers
- JC
5 papers
- LC
5 papers
- EB
4 papers
- RD
4 papers · 2 as a resident
Grants
- 2026–2031
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $815.4K · Boston University Medical Campus
- 2026–2028
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $204.4K · Boston University Medical Campus
- 2009–2015
Host Factors for Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $661.5K · Boston Children's Hospital
Yeast Engineering Technology & Immunobiology Core
National Institute of Allergy and Infectious Diseases · ZIC
Contact PI · $650.3K · National Institute of Allergy and Infectious Diseases





